Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene mutation
Research
Amish-linked gene variant reduces risk of heart disease
A genetic variant linked to Old Order Amish people that reduces LDL cholesterol and a blood clotting protein could inform new heart disease therapies.
Kyle LaHucik
Dec 6, 2021 8:50am
Vanderbilt team offers new clues for targeting p53
Sep 1, 2021 9:50am
Illumina CEO says U.S. behind on COVID-19 surveillance: CNBC
Jan 22, 2021 12:16pm
ESMO: Blueprint preps trial of drug for triple-mutant NSCLC
Sep 21, 2020 9:25am
Outsmarting COVID-19 by analyzing RNA in single cells
Aug 21, 2020 9:20am
Could the anti-cancer gene p53 be a target in kidney cancer?
Dec 20, 2019 9:42am